1 The place of medical treatment of acromegaly: current status and perspectives Expert Opinion on Pharmacotherapy, May 23, 2013 Review Article
2 Predicting difficult laryngoscopy in acromegalic patients undergoing surgery for excision of pituitary tumors: A comparison of extended Mallampati score with modified Mallampati classification Journal of Anaesthesiology Clinical Pharmacology, May 16, 2013
3 Ketoacidosis as the initial clinical condition in nine patients with acromegaly: A review of 860 cases at a single institute European Journal of Endocrinology, May 9, 2013 Review Article
4 Effects of Medical Therapies for Acromegaly on Glucose Metabolism European Journal of Endocrinology, May 13, 2013
5 Prevalence of cerebral aneurysm in patients with acromegaly Pituitary, May 21, 2013 Review Article
6 Complex Rhythmicity and Age Dependence of Growth Hormone Secretion Are Preserved in Patients With Acromegaly: Further Evidence for a Present Hypothalamic Control of Pituitary Somatotropinomas Journal of Clinical Endocrinology and Metabolism, May 3, 2013 Review Article
7 Circulating levels of pegvisomant and endogenous GH during prolonged pegvisomant therapy in patients with acromegaly Clinical Endocrinology, May 14, 2013 Review Article
8 Pituitary Adenoma with Mucin Cells in a Man with an Unusual Presentation of Carney Complex Endocrine Pathology, May 6, 2013
9 Predictors of endoscopic transsphenoidal surgery outcome in acromegaly: patient and tumor characteristics evaluated by magnetic resonance imaging Pituitary, May 21, 2013 Review Article
10 Pituitary carcinoma with endolymphatic sac metastasis Pituitary, May 6, 2013
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor